COMMUNIQUÉS West-GlobeNewswire
-
Acquisition of Own Shares
28/07/2026 -
Chemed Reports Second-Quarter 2026 Results
28/07/2026 -
Jushi Holdings Inc. Reports Second Quarter 2026 Financial Results
28/07/2026 -
Corporate Updates – NurExone appoints Mr. David Stolick to the Board of Directors
28/07/2026 -
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
28/07/2026 -
SodaSlim Introduces a Gummy Supplement Format as Part of Its Portfolio Expansion
28/07/2026 -
North Texas Plastic Surgery’s Dr. Sacha Obaid Named to Newsweek’s America’s Best Plastic Surgeons 2025 List
28/07/2026 -
EssilorLuxottica: Q2/H1 2026 Results - Solid revenue trajectory at +9.7% in H1, with Q2 at +8.7%. Increasing profitability, with Adj. Operating Profit +15%.
28/07/2026 -
Pennant Announces Second Quarter 2026 Earnings Release and Call
28/07/2026 -
Eurobio Scientific: Premier semestre 2026, Continuation de la transformation stratégique
28/07/2026 -
Eurobio Scientific: First half of 2026, Continuation of the strategic transformation
28/07/2026 -
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
28/07/2026 -
AscellaHealth Appoints Industry Veteran Johanna van Nijkerk as Vice President of Business Development to Advance National Accounts and Drive Growth of AscellaOne
28/07/2026 -
EssilorLuxottica: Résultats T2/S1 2026 - Trajectoire solide du chiffre d’affaires à +9,7 % au S1, avec un T2 à +8,7 %. Rentabilité en hausse, avec un résultat opérationnel ajusté progressant de +15 %.
28/07/2026 -
Colorectal Cancer Doesn’t Care How Young You Are
28/07/2026 -
Grief goes global on screen as first-of-its-kind festival receives over 500 films from six continents
28/07/2026 -
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
28/07/2026 -
Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
28/07/2026 -
Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK
28/07/2026
Pages